Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a research-based human health care (HHC) company that discovers, develops, and markets products throughout the world. Established in 1995, Eisai Inc. Backed by North Carolina Biotechnology Center.
About the role
At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease.
More about this role
At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference. If this is your profile, we want to hear from you.
The primary responsibility of the Director of Policy is to support Eisai’s engagement with the Centers for Medicare and Medicaid Services (CMS) to secure appropriate access to Eisai products by Medicare beneficiaries. The Director will work across Eisai’s entire portfolio, including in-line and pipeline treatments in Alzheimer’s Disease, neurology, and oncology. In addition, the Director will serve as an internal expert on Medicare Part D policy, Inflation Reduction Act implementation, drug pricing policy, and pharmaceutical...
Browse similar: Startup jobs